Systematic Screening of a Glycolysis-Targeting Small-Molecule Library Identifies Novel Inhibitors of Fungal Morphogenesis in Candida albicans
- 16 November 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
Abstract
Fungal infections are an increasing global health concern, with Candida albicans emerging as a leading cause of mucosal and life-threatening systemic infections. C. albicans relies on yeast-to-hyphae transition, to establish systemic infections in the host. Our recent work demonstrated that glycolysis is a key regulator of hyphal differentiation in C. albicans. Leveraging this knowledge, we screened a small-molecule compound library containing glycolysis inhibitors for their ability to block fungal morphogenesis and identified multiple small molecules that robustly block hyphal differentiation without compromising overall growth. Among these, two compounds (PKM2-IN-6 and NPD10084, both originally identified as modulators of human pyruvate kinase M2 (Pkm2) activity) emerged as the most potent inhibitors of fungal morphogenesis, significantly attenuating hyphal differentiation, in multiple filamentation-inducing conditions. Comparative RNA-Seq analysis revealed significant perturbation of glycolysis following PKM2-IN-6 treatment, while molecular docking analysis predicted that these compounds bind to specific pockets of pyruvate kinase in C. albicans. Interestingly, PKM2-IN-6 treatment resulted in the repression of multiple genes associated with fungal morphogenesis, biofilm formation, and virulence. These transcriptional changes were accompanied by a significant reduction in biofilm formation and increased sensitivity to conventional antifungal drugs, including amphotericin B and fluconazole, in the presence of both compounds, PKM2-IN-6 and NPD10084. Furthermore, administration of PKM2-IN-6 significantly improved the survival of mice in a murine model of systemic candidiasis underscoring the in vivo efficacy of this compound. Collectively, our study has identified novel small molecules that target fungal morphogenesis and virulence in C. albicans, establishing inhibition of glycolysis as a promising antifungal strategy.Funding Information
- Indian Council of Medical Research (IIRPSG-2024-01-02717)
- Department of Biotechnology, Ministry of Science and Technology, India (NNP-BT/PR40189/BTIS/137/50/2022)
This publication has 68 references indexed in Scilit:
- Morphogenic plasticity: the pathogenic attribute of Candida albicansCurrent Genetics, 2023
- Identification of a Small Compound Targeting PKM2-Regulated Signaling Using 2D Gel Electrophoresis-Based Proteome-wide CETSACell Chemical Biology, 2020
- Proteomic analysis uncovers the modulation of ergosterol, sphingolipid and oxidative stress pathway by myristic acid impeding biofilm and virulence in Candida albicansJournal of Proteomics, 2019
- Regulation of pyruvate metabolism and human diseaseCellular and Molecular Life Sciences, 2013
- Carbon source‐induced reprogramming of the cell wall proteome and secretome modulates the adherence and drug resistance of the fungal pathogen C andida albicansProteomics, 2012
- A Recently Evolved Transcriptional Network Controls Biofilm Development in Candida albicansCell, 2012
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Hyphal formation of Candida albicans is controlled by electron transfer systemBiochemical and Biophysical Research Communications, 2006
- Regulation of Cell-Surface Genes and Biofilm Formation by the C. albicans Transcription Factor Bcr1pCurrent Biology, 2005
- The metabolism of lactateNMR in Biomedicine, 1991